These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 20231193

  • 1. Minimally important difference for patient-reported outcomes in psoriatic arthritis: Health Assessment Questionnaire and pain, fatigue, and global visual analog scales.
    Kwok T, Pope JE.
    J Rheumatol; 2010 May; 37(5):1024-8. PubMed ID: 20231193
    [Abstract] [Full Text] [Related]

  • 2. The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma.
    Sekhon S, Pope J, Canadian Scleroderma Research Group, Baron M.
    J Rheumatol; 2010 Mar; 37(3):591-8. PubMed ID: 20080913
    [Abstract] [Full Text] [Related]

  • 3. The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36.
    Colangelo KJ, Pope JE, Peschken C.
    J Rheumatol; 2009 Oct; 36(10):2231-7. PubMed ID: 19723907
    [Abstract] [Full Text] [Related]

  • 4. The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials.
    Pope JE, Khanna D, Norrie D, Ouimet JM.
    J Rheumatol; 2009 Feb; 36(2):254-9. PubMed ID: 19132791
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsger TA, Rothfield NF, Ellman MH, Collier DH, Weinstein A, Furst DE, Jiménez SA, White B, Seibold JR, Wigley FM, Scleroderma Clinical Trials Consortium.
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [Abstract] [Full Text] [Related]

  • 15. Patient-reported Health-related Quality of Life with apremilast for psoriatic arthritis: a phase II, randomized, controlled study.
    Strand V, Schett G, Hu C, Stevens RM.
    J Rheumatol; 2013 Jul; 40(7):1158-65. PubMed ID: 23588944
    [Abstract] [Full Text] [Related]

  • 16. Using Rasch analysis to compare the psychometric properties of the Short Form 36 physical function score and the Health Assessment Questionnaire disability index in patients with psoriatic arthritis and rheumatoid arthritis.
    Taylor WJ, McPherson KM.
    Arthritis Rheum; 2007 Jun 15; 57(5):723-9. PubMed ID: 17530670
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of the Health Assessment Questionnaire and Arthritis Impact Measurement Scale in patients with psoriatic arthritis.
    Taccari E, Spadaro A, Rinaldi T, Riccieri V, Sensi F.
    Rev Rhum Engl Ed; 1998 Dec 15; 65(12):751-8. PubMed ID: 9923043
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.